Allergy Therapeutics PLC has named Helge Weiner-Trapness, a former HSBC banker with over 30 years of experience, as its new executive chairman. He joined the company earlier this year as chief strategy officer and executive director. His appointment comes as the biotech firm explores a dual primary listing in Hong Kong to access new markets, expand in Asia, and boost R&D. He replaces Peter Jensen OBE, who is stepping down after 15 years but will stay on the board during the transition.
Alstom and its consortium partners have reached financial close for the Haifa-Nazareth light rail project in Israel, a major step enabling full-scale execution. The €2 billion project will build a 41-kilometer light rail line connecting Haifa, Nazare...
Alstom and its partners have finalized financing for the Haifa-Nazareth light rail project in Israel, valued at around €2 billion, with Alstom's share at approximately €750 million. The 41-kilometer line will connect Haifa, Nazareth, and nearby commu...
The global strategy consulting market, valued at $81.51 billion in 2025, is projected to grow to $194.56 billion by 2035 with a CAGR of 9.09%. Growth is fueled by increasing demand for digital transformation, AI-powered advisory services, ESG consult...
The global pharmaceutical surfactants market, valued at $4.5 billion in 2025, is projected to grow to $6.93 billion by 2035 at a CAGR of 4.42%. Growth is fueled by increasing use in drug formulation to enhance solubility, stability, and bioavailabili...
Schall Brown & Schwartz LLP announced a class action lawsuit against Black Rock Coffee for allegedly issuing false or misleading financial statements and failing to disclose important information. The lawsuit covers the period from September 12, 2025...
